Iron & TIBC
For informational purposes only — not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen. Full disclaimer →
- Iron is one of the few nutrients where both deficiency and excess cause serious harm. Most nutritional markers have a single direction of concern. Iron is bidirectional: deficiency impairs energy, cognition, and immune function; excess drives oxidative damage linked to cardiovascular disease, neurodegeneration, and liver disease. The iron panel differentiates these opposite states — ferritin alone cannot.
- Transferrin saturation is the most sensitive functional marker of iron status. Serum ferritin reflects storage but is confounded by inflammation (ferritin rises as an acute-phase reactant during illness regardless of iron stores). Transferrin saturation reflects what is actually happening at the transport and tissue-delivery level and is less affected by inflammatory state.
- Pre-anemic iron deficiency is widespread and underdiagnosed. Hemoglobin doesn't fall until iron stores are severely depleted. Symptoms — fatigue, cold intolerance, poor concentration, exercise intolerance, hair loss — begin when ferritin drops below 30–50 ng/mL and transferrin saturation falls below 20%, often months to years before hemoglobin shifts. The iron panel identifies this stage.
- Hereditary hemochromatosis is the most common serious genetic disorder in populations of Northern European descent and is almost always identified through iron panel abnormalities. Transferrin saturation persistently above 45–50% in a fasting state, especially with elevated ferritin, should prompt HFE gene testing regardless of symptoms. Most people with hemochromatosis are asymptomatic for decades while iron accumulates in the liver, heart, and joints.
- Iron overload accelerates aging through iron-catalyzed oxidative stress. Excess free iron drives the Fenton reaction, producing hydroxyl radicals that damage DNA, proteins, and cell membranes. This mechanism is a direct contributor to the accelerated cardiovascular and liver disease seen in hemochromatosis — and elevated-normal iron status in the general population is associated with higher cardiovascular mortality on a population level.
The Two-Way Street: Why Iron Is Unlike Most Nutrients
Most nutritional biomarkers point in one direction. Low vitamin D means supplement more. Low zinc means eat more oysters or take a supplement. The intervention logic is straightforward because deficiency is the primary concern for almost all micronutrients.
Iron is different. Iron occupies one of the only positions in longevity biology where both too little and too much accelerate aging — through entirely distinct mechanisms — and where the same basic panel can identify which direction the problem lies in a given person.
Iron deficiency is far more familiar in clinical medicine: fatigue, poor exercise tolerance, cognitive fog, cold intolerance, hair loss, restless legs. These symptoms accumulate gradually, often attributed to stress or poor sleep, while the underlying cause is a depleted iron supply to mitochondria, tissues, and the brain. What is less appreciated is how early these symptoms begin — typically months to years before anemia appears on a CBC.
Iron excess is less discussed but equally important for longevity. Excess iron drives the Fenton reaction — a well-characterized chemical pathway in which ferrous iron (Fe²⁺) reacts with hydrogen peroxide to generate the hydroxyl radical (·OH), one of the most reactive and damaging oxidants in biology. This iron-catalyzed oxidative stress damages DNA, proteins, lipid membranes, and mitochondria, and is a mechanistic driver of atherosclerosis, neurodegeneration, liver fibrosis, and pancreatic beta cell damage. The elevated cardiovascular and all-cause mortality seen in hereditary hemochromatosis is the clearest demonstration of this pathway in humans — but population data suggest even elevated-normal iron status in the general population carries meaningful risk.
The iron panel — serum iron, TIBC, and transferrin saturation, interpreted alongside ferritin — maps both sides of this distribution and is among the most actionable standard blood tests available.
Reading the Iron Panel: Four Values, One Story
The iron panel contains multiple numbers that are most meaningful in combination, not in isolation.
Serum iron measures the iron circulating in blood bound to transferrin right now. It fluctuates with time of day (diurnal variation peaks in the morning), meals, and acute stress or illness. Used alone, it's the least stable and least interpretable marker — its primary value is in calculating transferrin saturation.
TIBC (Total Iron Binding Capacity) measures the maximum amount of iron transferrin could carry if fully loaded. It inversely reflects iron stores: when iron is deficient, the body produces more transferrin to capture every available iron atom, raising TIBC. When iron is abundant or overloaded, transferrin production drops, lowering TIBC. A high TIBC is a sign of iron need; a low TIBC is a sign of iron sufficiency or overload.
Transferrin saturation (serum iron ÷ TIBC × 100) is the functional quotient — the percentage of transferrin that is currently loaded with iron. It's the most immediately informative number in the panel: below 20% indicates iron deficiency at the transport level; above 40–45% indicates the transport system is overloaded, a flag for hemochromatosis screening.
Ferritin (ordered separately) completes the picture by measuring long-term storage reserves. Low ferritin plus low transferrin saturation confirms iron deficiency. High ferritin plus high transferrin saturation confirms iron overload. The critical edge case: normal or elevated ferritin with low transferrin saturation can indicate functional iron deficiency in an inflammatory state — the body has stored iron but cannot mobilize it effectively, a pattern seen in chronic disease and after inflammatory illness.
| Pattern | Transferrin Sat. | Ferritin | Interpretation |
|---|---|---|---|
| Iron deficiency (pre-anemic) | < 20% | < 30 ng/mL | Depleted stores + reduced transport |
| Functional deficiency | < 20% | Normal–High | Inflammation blocking iron mobilization |
| Longevity optimal | 25–40% | 50–100 ng/mL | Adequate supply, no overload signal |
| Iron overload concern | > 45% | > 200 ng/mL | Screen for hemochromatosis (HFE gene) |
Hemochromatosis: The Hidden Common Condition
Hereditary hemochromatosis — caused primarily by mutations in the HFE gene, particularly C282Y — affects approximately 1 in 200 people of Northern European descent, making it one of the most common serious genetic disorders in this population. Despite its prevalence, it remains dramatically underdiagnosed, largely because its early manifestations (fatigue, joint pain, elevated liver enzymes) are nonspecific and attributed to other causes.
Hemochromatosis causes excessive iron absorption from the gut. Since humans have no regulated mechanism for iron excretion (iron is lost only through blood loss and sloughing of skin and gut cells), excess absorbed iron accumulates progressively in the liver, heart, joints, and endocrine glands. Without detection and treatment, this accumulation produces cirrhosis, cardiomyopathy, diabetes, arthropathy, and hypogonadism over a 20–40 year timeframe.
The treatment is simple and highly effective: therapeutic phlebotomy (regular blood donation or medical blood removal). Started before organ damage occurs, it normalizes life expectancy. Started after cirrhosis has developed, it cannot reverse the damage.
The identification point is the iron panel. A fasting transferrin saturation persistently above 45%, particularly with rising ferritin, should prompt HFE gene testing in any adult — regardless of symptoms. The test costs under $50 and finds a treatable condition that otherwise presents as a preventable multi-organ failure in middle age. 1
| Range Type | Value (μg/dL (serum iron, TIBC); % (transferrin saturation)) | Notes |
|---|---|---|
| Standard Clinical Range | Serum iron: 60–170 μg/dL (men and women) · TIBC: 240–450 μg/dL · Transferrin saturation: 20–50% | Designed to identify disease risk — not longevity optimisation. |
| Longevity-Optimal Target | Serum iron: 70–130 μg/dL · TIBC: 250–370 μg/dL · Transferrin saturation: 25–40% |
Associated with reduced all-cause mortality and extended healthspan.
The standard clinical range for transferrin saturation extends to 50%, but longevity-focused interpretation targets the lower portion of that range. A transferrin saturation consistently above 40–45% in an otherwise healthy adult warrants investigation for iron overload — particularly hereditary hemochromatosis, which affects approximately 1 in 200 individuals of Northern European descent and is dramatically underdiagnosed. Transferrin saturation below 20% combined with low ferritin (<30 ng/mL) confirms iron deficiency, even if hemoglobin is still normal — pre-anemic iron depletion is common and produces meaningful symptoms years before anemia develops.
|
Already have your results? See what your Iron & TIBC and other markers reveal about your longevity in 60 seconds.
Analyze My Labs →Affiliate disclosure: we may earn a commission if you purchase through these links at no extra cost to you.
What's the difference between serum iron, TIBC, ferritin, and transferrin saturation — which one actually matters?
Each measures a different aspect of iron metabolism, and you need at least two or three to interpret iron status accurately. Serum iron measures circulating iron right now — it fluctuates significantly hour to hour and day to day based on recent meals and diurnal variation, so it's the least reliable in isolation. TIBC reflects the blood's iron-carrying capacity — essentially how much transferrin is available, which rises when the body needs more iron and falls when iron is abundant. Transferrin saturation (serum iron ÷ TIBC × 100) is calculated from both and is the most functionally meaningful number — it tells you whether the transport system is overloaded or underutilized. Ferritin is the storage marker, reflecting how much iron is in tissue reserves. For complete iron assessment: ferritin tells you about long-term stores, transferrin saturation tells you about current transport function, and together they can identify deficiency (low ferritin + low transferrin saturation), overload (high ferritin + high transferrin saturation), or functional deficiency in inflammatory states (normal ferritin but low transferrin saturation, because inflammation elevates ferritin artificially).
Can I have iron deficiency with a normal CBC?
Yes — and this is one of the most commonly missed scenarios in routine medicine. Hemoglobin and red blood cell parameters (MCV, MCH) don't fall until iron stores are severely depleted. The sequence of iron depletion runs: iron stores deplete (low ferritin, low transferrin saturation) → functional iron deficiency (symptoms begin: fatigue, cold intolerance, cognitive effects, exercise intolerance) → finally, iron deficiency anemia (hemoglobin drops, MCV falls, microcytic anemia appears). Many people experience months to years of symptoms in the functional deficiency stage before anemia develops. A CBC alone misses this entirely. The iron panel with ferritin identifies pre-anemic iron depletion — the stage where intervention is most effective and easiest.
I've heard that high iron is bad for longevity — should I be worried about iron in my supplements?
This concern has merit, though context matters. The research connecting iron overload with accelerated aging and cardiovascular disease comes primarily from people with hereditary hemochromatosis (who accumulate iron due to a genetic defect in iron regulation) and from population studies showing elevated transferrin saturation is associated with higher cardiovascular mortality. For people without hemochromatosis, the body normally regulates iron absorption efficiently — excess dietary iron is largely not absorbed. However, supplemental iron in adults without documented deficiency is generally not recommended precisely because it bypasses some regulatory mechanisms and can increase iron absorption in amounts the body doesn't need. Adults who are not iron deficient should not take iron supplements without a clinical reason. The iron panel is the tool that answers whether your specific iron status is appropriate.
How should iron be tested — are there any preparation requirements?
For the most accurate serum iron and transferrin saturation results, the test should be drawn in the morning after an overnight fast, since iron levels vary significantly with food intake and show diurnal variation (highest in the morning, lower in the evening). TIBC and ferritin are less affected by timing, but fasting sampling standardizes interpretation. For the most accurate iron panel interpretation, testing should not be done within a few weeks of acute illness or significant inflammation, since both serum iron (which falls during inflammation) and ferritin (which rises as an acute-phase reactant) are meaningfully affected by inflammatory state — creating false appearances of deficiency or adequacy depending on which marker you're looking at.
What transferrin saturation level should prompt concern about hemochromatosis?
A fasting transferrin saturation above 45% on at least two separate measurements is the standard threshold for further hemochromatosis workup, particularly in adults of Northern European descent. Above 45%, HFE gene testing (looking for the C282Y and H63D mutations) is appropriate regardless of symptoms, since hemochromatosis causes organ damage silently for years before symptoms appear. If the common HFE mutations are not found but transferrin saturation remains elevated with rising ferritin, hepatology or hematology referral for evaluation of non-HFE iron overload is warranted. Hemochromatosis is highly treatable (therapeutic phlebotomy normalizes iron stores) — the key is catching it before significant organ damage occurs, which is why the iron panel is particularly valuable as a screening tool.